In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Zhejiang Huahai Pharmaceutical Co., Ltd.

http://en.huahaipharm.com

Latest From Zhejiang Huahai Pharmaceutical Co., Ltd.

China Braces As Trump Orders 'Buy American' For Essential Medicines

As the largest manufacturer of active pharmaceutical ingredients globally, China is bracing for more uncertainty amid the global pandemic and fast-changing environment, particularly in the US.

Manufacturing Ingredients

EU Takes Lessons From Valsartan Crisis

EU report on “lessons learnt” from the valsartan crisis calls for tighter GMP controls on API suppliers.

Manufacturing Generic Drugs

The EU's Top Valsartan Lesson: Closely Examine Active Substance Manufacturing Processes

EU report on “lessons learnt” from the valsartan crisis calls for tighter GMP controls on API suppliers.

Manufacturing Quality

Regulatory Overhang Hurts Torrent

Torrent has tempered US growth expectations while it plans to put its Dahej, Indrad and Levittown plants up for FDA inspection in 2020. Meanwhile, products launched in India, including remoglifozin in-licensed from Glenmark, have shown an encouraging uptake.

Sales & Earnings Regulation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Other Names / Subsidiaries
    • Huabo Biopharm Co., Ltd.
UsernamePublicRestriction

Register